Login / Signup

Development and characterization of a multimeric recombinant protein using the spike protein receptor binding domain as an antigen to induce SARS-CoV-2 neutralization.

Veronica A de LimaJoão P S NunesDaniela S RosaRodrigo FerreiraMaria L V OlivaRobert Andreata-SantosMarcia Duarte-BarbosaLuiz M R JaniniJuliana T MaricatoMilena A AkamatsuPaulo L HoSergio Schenkman
Published in: Immunity, inflammation and disease (2024)
These results add a new arsenal to combat COVID-19, as an alternative immunogen or antigen for diagnosis.
Keyphrases
  • sars cov
  • binding protein
  • coronavirus disease
  • protein protein
  • respiratory syndrome coronavirus
  • amino acid
  • small molecule